Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre

Warning LetterOpen

Recipient Name Mukesh B. Chandre, M.D., MBBS, Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre, Maratha Section, Near Jijamata Udhyan Ulhasnagar 421004 Maharashtra IndiaIssued Apr 29, 2026Center for Drug Evaluation and Research (CDER)

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations4

Issue DateApr 29, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre
Location: Recipient Name Mukesh B. Chandre, M.D., MBBS, Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre, Maratha Section, Near Jijamata Udhyan Ulhasnagar 421004 Maharashtra India
FEI Number: N/A
Country: India
Issue Date: April 29, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

In Vivo Bioavailability-Bioequivalence Studies – Clinical

Mukesh B. Chandre, M.D., MBBS/Ashirwad Hospital & Research Centre FDA Warning Letter, April 29, 2026